U-ABBV

Z:ABBV - ABBVIE INC - http://www.abbvie.com

15:04:58 EDT

Sym-X	Bid - Ask					Last	Chg	%Ch	Vol	$Vol	#Tr	Open-Hi-Lo	Year Hi-Lo	Last Tr	News	Delay
ABBV - Z	0.1	166.77	·	166.80	0.2	166.77	-1.03	-0.6	3,067.3	509,615	32,935	167.795 169.14 165.59	182.89 130.9601	14:48:01	08:00	15 min RT 2¢

Trade times are ET. News times are ET. Bid/ask/vol sizes in thousands.

Fundamentals · Holders · Trade Workstation · Market Depth · 3 Month Closes · Technical Charts 1 yr | 2 yr | 3 yr | 5 yr | 10 yr | 15 yr | 20 yr · Live Charts 1 yr | 1 day · 1yr Bulletins · Historical · Options · Portfolio

Recent Trades - Last 10 of 32935

Date ET	Symbol	Type	Headline
2024-04-25 08:00	U:ABBV	News Release200	New Data Show RINVOQ(TM) (upadacitinib) Demonstrated Superiority Versus DUPIXENT(TM) (dupilumab) Across Primary and All Secondary Endpoints in an Open-Label Head-to-Head Atopic Dermatitis Study
2024-04-23 08:00	U:ABBV	News Release200	Allergan Aesthetics Invites Consumers to Be the Face of BOTOX(TM) Cosmetic (onabotulinumtoxinA) and Their Other Biggest Brands
2024-04-18 08:31	U:ABBV	News Release200	Phase 3 SELECT-GCA Study of Upadacitinib (RINVOQ(TM)) Showed Positive Results in Patients With Giant Cell Arteritis
2024-04-12 07:30	U:ABBV	News Release200	AbbVie Announces Late-Breaking Data at AAN Supporting Long-Term Safety and Efficacy of Atogepant (QULIPTA(TM)) for Preventive Treatment of Migraine
2024-04-09 08:00	U:ABBV	News Release200	SkinMedica(TM) Empowers Clear Skin Confidence with a New, Modern Approach to Acne
2024-04-04 08:00	U:ABBV	News Release200	AbbVie to Host First-Quarter 2024 Earnings Conference Call
2024-04-03 08:30	U:ABBV	News Release200	Allergan Aesthetics Announces the Return of CoolMonth with CoolSculpting(TM)
2024-04-01 07:50	U:ABBV	News Release200	NEXGEL Reports Full Year 2023 Revenue of $4.1 Million, an Increase of 99.7% Year-Over-Year

Date ET

Symbol

Type

Headline

2024-04-25 08:00

News Release

2024-04-23 08:00

News Release